I’m a D Cup, and This Girlfriend Collective Sports Bra Is Supportive Without Sacrificing Style

Fitness

To be 100-percent real, nothing motivates me to exercise more than some new workout clothes. The cute-but-sweaty selfie is underrated, people! Whether I’m going for a run or taking a yoga class in my living room, it’s important for me to wear comfortable, well-made pieces that I don’t have to constantly adjust. They also can’t be hot, because the temperatures have been crazy high these days. That’s why I was excited to test out Girlfriend Collective‘s newest drop, Float Activewear ($38-$68).

Float promises to be lightweight and soft: the ideal pieces for summertime “lounging or lunging,” as the brand says. I can confirm that as soon as I opened my package, I muttered “oh, damn” to myself because the fabric was so smooth and luxurious. If you’re worried about these leggings slipping down or the bra riding up, don’t be. I’m a D cup and wore a size large in both of my pieces; I don’t have to tug or adjust anything for hours.

As soon as I opened my package, I muttered “oh, damn” to myself because the fabric was so smooth and luxurious.

The sports bra is quite supportive — my boobs don’t bounce while I’m running and the straps don’t dig into my shoulder. The same goes the leggings: they stay tight to my body and never sag. Overall, this is my dream set, and I love it so much I’m going to buy it in another color. I test tons of activewear as a shopping editor, and this is my sincere take on Float.

Ahead, check out how the set looks on me, then shop the pieces I wore. This incredibly popular collection is selling out fast, so get what you can before it’s all gone.

Products You May Like

Articles You May Like

Why Americans are outraged over health insurance — and what could change
Dexcom’s over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
What Is Crohn’s Disease? Gastro Docs Explain the Chronic Condition
Peppermint Meringues
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Leave a Reply

Your email address will not be published. Required fields are marked *